Introduction
Childhood enuresis is a common condition. Braithwaite (5) reported that 22% of 500 unselected English children between the ages of four and 14 years attending out-patient clinics were, or had been, enuretic, and Kanner (18) found that 26% of cases referred for psychiatric consultation to the children's clinic at the Johns Hopkins Hospital were enuretic. A wide variety of treatments has been advocated; within the past decade, these have included irradiation of the diencephalon and cervical sympathetic system (31) , injection of xylocaine into Retzius' space ( 13) and lumbopubic electroshock (29) . On this Continent and in England treatment approaches are more conservative and may be classified as:-1) General measures; reassurance of child and parents, limitation of fluid intake, avoidance of excessive fatigue or excitement, night waking 2) Psychotherapy 3) Drug therapy 4) Conditioning procedures. The first three are frequently employed in variable combination.
The rapidity with which new drugs now become available make it crucial that they be subject to very careful investigation to determine whether they are effective, whether any positive effect is sufficient to be of practical value and the nature and severity of side effects. At present such critical evaluation is very uncommon (2) .
Enthusiastic reports on the use of imipramine in nocturnal enuresis have recently appeared and this paper reports a controlled study of this drug.°T ofranil, Geigy Pharmaceuticals. 'Clinical Director, Thistletown Hospital, Rexdale, Onto and Clinical Teacher, Dept. of Psychiatry, University of Toronto. Method a) Subjects: All enuretic children at Thistletown Hospital were included except those on the research unit for schizophrenia. In all cases the enuresis was nocturnal. As there were initially only five subjects, other patients were included as they were admitted, and a total of twelve cases obtained. The age at the beginning of the study (years, months), sex and primary diagnosis of these cases appears in Table I . The severity of the personality disturbance has been roughly quantified into slight, moderate or severe. None was defective. b) Experimental Design: Each subject served as his own control and received either a 25 mgm imipramine tablet or identical placebo tablet at 8 p.m. The design was double-blind and the drug or placebo given for a minimum of two weeks and a maximum four weeks at a time. The shortest total combined period on drug and placebo was 16 weeks for the later admissions, the longest 32 weeks. In eleven of the twelve cases the observations were available for 21 days before commencing drug or placebo, in nine for 21 days after the drug trial and in eight of these for a further 42 days. Obser.vations were made by the child-care staff between midnight and 1 a.m, and between 6 and 7 a.m., and if found wet the time was noted but the child was not awakened. If he woke spontaneously and the enuresis first became known then, that time was recorded. No control of fluid intake or other measures directed to the enuresis were employed. When drug or placebo were first given, the child's psychiatrist told him that the tablet was to help his bedwetting but no further explanations were given. Only observations made at the hospital were included; if the child was away on a visit or sick, no record was made. 
Results
The total enuretic nights were calculated for each experimental condition i.e. 21 days before the trial (N,), placebo (P), drug (D), 21 days after the trial (N.) and 42 days after that (N.). This total was expressed as a percentage of the total nights for which data was available for each condition. For the entire group enuretic nights declined from 46.75% on placebo to 31.7 5% on drug, a reduction of the placebo level by 32.09%. For the eleven cases for whom N , data and the ten cases for whom N, data were available, the percentages were 57.58 and 47.9'4 respectively. Enuresis declined per child from an average of 47.25% on placebo to 30.75% on drug, a reduction of the placebo level of 34.92 %. The average enuresis per child before the trial (N,) was 57.45% and after (N.) was 44.20%. The corresponding figures for the nine children for whom both N , and No observations were obtained were 55.89% and 43.78% respectively. Comparing the experimental conditions using the Wilcoxon Matched Pairs Signed Ranks Test a highly significant reduction in enuresis on the drug was demonstrated (Table II) . None of the other conditions differed significantly among themselves.
Individual responses are shown in Table III . In each cell the total number of nights is shown in parenthesis, below this the number 'of nights enuretic and below this the percentage of nights enuretic. Compared to the nothing condition before drug or placebo, enuresis declined on drug in all eleven cases for whom N , observations were available. Enuresis declined on drug compared with placebo except for subject 12 who became virtually dry on placebo. The reduction in enuretic nights on drug as a percentage of placebo level, appears at the bottom of the table. In five of the eleven cases the reduction exceeded 40%.
The X. values and levels of significance for the conditions N , : P, P: D, N ,: No, N« N. are shown for each child in Table  IV . In seven children there was a significant reduction in enuretic nights on the drug. Two of these showed a reduction of 70% or more, three of 50% or more and all of 25% 'Or more. In two of these the enuresis remained significantly lower in the 21 days post-trial, but the effect had disappeared in the case on whom a further 42 days' observation was made. Three patients showed a placebo effect, emphasizing the need for a controlled trial. One (subject 12) ceased to be enuretic from the second night of tablets (placebo) and during the' 202 days of the trial wet the bed only once. This followed an incident of firesetting; she was on drug. The other two showed no response to the drug. The placebo effect persisted throughout the 63 days posttrial period in the two cases for whom this data was available, in contrast to the rapid relapse of the drug responders. There was no relationship between the initial level of enuresis and response to the drug, nor between the enuresis level on drug and the increase from drug level to post-trial level.
In order to study more closely the response to the drug, the first block of weeks taking the form PPDDDDPP was selected for each subject. The number of enuretic nights in each of these weeks was obtained for each subject (prorating where necessary). The average number of enuretic nights under each condition is shown in Figure 1 . A Friedman two-way analysis of variance confirms a significant decline in enuresis while on drug (X'. = 17.317 P = <.05 df=8). It will be observed that the enuresis level in the final placebo week was below that in the placebo week preceding administration of the drug. The average weekly enuresis for each child was then obtained for each block of conditions (PI = first block of time on placebo, P. = second block of time on placebo and so on). Nine patients had seven blocks (NI, PI, DI,P., D., P., N.) and seven had in addition N. data. The results appear in Table V and Figure II . Two trends are evident; firstly a reduction in enuresis on drug compared with placebo, but secondly an over-all decrease in enuresis. Thus PI is greater than P. and P. greater than P., just as DI is greater than D.. This latter trend could result from spontaneous improvement with time, but the increase of enuresis from N. to a level during N. almost as great as N , does not support this view. An alternative and more probable explanation is that the maximum effect of the drug is delayed to some extent and that its effects take some time to wear off. This second hypothesis needs further research for it has obvious implications regarding the validity of drawing general conclusions about such a drug on the basis of the usual brief drug trial.
It has been suggested that imipramine acts by causing urinary retention, difficulty in initiating micturition having been reported in adult patients receiving the drug (20) . If this were so, it would be predicted that when enuresis occurred during drug administration it would tend to occur later than on placebo. To test this hypothesis incidents of enuresis were divided into those occurring before 1 a.m. and those after 1 a.m, The latter consisted of children found to be enuretic when examined between 6 a.m. and 7 a.m. together with those who woke spontaneously between 1 and 6 a.m, and had been enuretic (The total enuretic Table VI . When the number of days on drug differ from days on placebo, the former were prorated to facilitate comparison. From this it can be seen that the prediction is born out only in subject 2, in whom, in spite of a significant over-all reduction in enuresis and a reduction of incidents before 1 a.m. by 57%, those after 1 a.m. are increased by 21%. The most frequent pattern was for incidents after 1 a.m. to be reduced while those before 1 a.m. were unchanged (subjects 3, 4, 5 and 9) but in the first subject the reduction in the number of enuretic nights did not reach significance.
In subjects 8 and 11 the incidents on placebo before 1 a.m. were too few to draw conclusions, although reduction on drug after 1 a.m, is impressive. Only in subject 1 was an equal reduction before and after 1 a.m. observed. Thus of the seven children whose enuretic nights were significantly reduced by the drug, in three the effect seemed to be limited to after 1 a.m., in one child incidents were reduced equally and in one case only were incidents before 1 a.m, controlled at the expense of an increase after 1 a.m. No side effects were encountered at any time during the study.
Discussion
This investigation demonstrated that imipramine produced a useful reduction in enuresis in a sample of emotionally disturbed children. The drug was administered at 8 p.m. which would normally be not more than an hour before bedtime.
The results indicate that in only two subjects whose enuresis responded, (subjects 1 and 2) was significant drug effect taking place before 1 a.m. This would suggest that better results might have been obtained in subjects 3, 4, 5 and 9 had the drug been given four or five hours earlier. The delayed increase in enuresis in subject 2 suggests that increasing the 8 p.m. dose to 50 mgm might have maintained effective control throughout the night.
Since Maclean reported on the use of imipramine in enuresis in 1960, a number of studies have appeared. Maclean (20) described a marked symptomatic effect in a mixed adult and child population, using 25 mgm for those aged 12 years or less and 50 mgm for those older, and this dosage has been generally adopted. However, his investigation was uncontrolled and no definite conclusions can be drawn. Munster et at (26) used the. same dosage in 16 female patients aged eight to 16 years and reported enuresis alleviated in all cases with a response following the first dose and enuresis recurring as soon as the drug was discontinued. Use of placebo was thought to be unnecessary since previous use of tranquillizers had been ineffective; this is a doubtful assertion. Margolis (21) in another uncontrolled investigation reported immediate relief of enuresis in three children aged eight, nine and 12t years. Schunzelaar (32) , in a group of 20 chronic hospitalized patients who were mostly psychotic, aged 34-81 years, using a dosage of 50-100 mgm. found that eight cases showed an 80% improvement and seven a 40 -75'% improvement. Placebo was not used and the improve- After basal observations, drug or placebo were given for four weeks and then reversed. Eight ceased enuresis when administered either drug or placebo and remained practically dry until receiving nothing. Only four cases remained; one improved more on placebo than drug and three more on drug than placebo but the differences were not significant. Since the completion of the present study, Mariuz and Walters (22) reported a double-blind trial involving 23 psychiatrically disturbed patients aged five to 11 years in an institution for dependant and neglected boys. After initial observations, 11 subjects received 25 mgm imipramine and 12 placebo for 20 days, after which conditions were reversed. A highly significant response to the drug was found with a marked improvement in 17 boys and a reduction of enuresis from a mean of 70% to 47%.
The mode of action of the drug is uncertain. Cystometric studies by Nash (27) described the occurrence of uninhibited bladder contractions in half of the enuretics studied, which led finally to micturition. In the normal child the desire to micturate arises when about 100 mls. have been slowly introduced into the bladder and again at about 200 mls, This is not associated with any rise in intravesical pressure which very gradually increases as the bladder fills, but remains below 20 ems, water. When capacity is reached an intense desire to micturate occurs and emptying becomes essen-tial. However, pressure still does not rise above 20 ems, water.
Braithwaite (5) in 117 enuretics found that their bladders contracted after introduction of only small volumes of fluids. A desire to micturate, occurred with less than 100 mls. in all but four and in 58 patients with less than ten mls. Braithwaite suggested that there was a failure of the detrusor to relax and an abnormal depth of sleep so that detrusor contractions failed to cause waking. Ditman and Blinn (9) found that enuresis occurred during deep sleep in children (but not adults) using EEG and other physiological measures. McLellan (25) described two types of abnormal bladder function in severe enuresis; uninhibited rhythmic contractions of the detrusor occurring after the introduction of 25-75 mls, fluid, increasing in intensity until the bladder was filled, or a smooth rise in pressure until bladder filling was completed and then there was an imperative need to empty. These findings were confirmed by Stockwell and Smith (34) . Similar cystometric findings to the first of these types were reported by Forsythe and Karlan (12) in seven of 25 young male enuretics and ascribed to "a genesis of bladder-inhibiting tracts". Bakwin con-c~u?:s that there is a difficulty in in-l1bItI?"g the~ladder-emptying mechan-Isms 111 enuresis. .~ltho,!gh i~has been suggested that Imipramme l1l1ght act by causing urinary retention, retention after waking has not been reported in patients whose improvement was attributed to the drug and was not encountered in the present subjects. It seems more probab:le that the tendency for uninhibited bladder contractions to occur is diminished.
The posterior hypothalamus is an important centre for the control of the sympathetic division of the autonomic nervous system. The sympathetic innervation of the bladder is believed to diminish the tone of the detrusor and increase that of the internal sphincter. Both deep sleep (i.e. lack of normal arousal) and the failure of the detrusor to relax normally with increasing urinary volume may be considered to reflect a lack of central response to afferent bladder stimuli. Atropine, which blocks the action of acetyl choline, has for years been used in the treatment of enuresis and Amberg and Grob (3) reported a lowering of bladder pressure following hypodermic injection of atropine. Pefialoza-Rojas et at (28) found in experimental studies with cats that low doses (two to five mg kilo) of imipramine lowered the threshold for responses elicited by posterior hypothalamic stimulation. Gershon et aJ (14) and Sigg (33) have both commented on the drug's adrenergic effects and the latter suggested these resulted from sensitization of central adrenergic synapses. It is therefore possible that imipramine acts in enuresis by increasing, at the diencephalic level, the sympathetic response to afferent bladder stimuli from stretch receptors.
Investigation of other drugs in the treatment of enuresis during the past decade, using double-blind design, has yielded modest results. Holt (16) Leys (19) Mayon-White (24) Wilken-Jensen (35) and Jones and Tibbetts (17) studied pro banthine. Only Leys reported a statistically significant effect from the drug but from the methodological standpoint the results do not appear to justify the conclusions drawn. Meprobamate (6) hydroxyzine hydrochloride and methylphenidate (7) were found by Breger to have no statistically significant effects in patients aged five to 14 years. Holt (16) and Marson (23) reported that posterior pituitary snuff improved enuresis but the results of Jones and Tibbetts (17) indicate no significant effect. Harrington (15) concluded that phenmetrazine was effective. However he made no adequate statistical analysis of his data and when this is done no significant difference between drug and placebo emerge.
It is evident that imipramine is a drug producing both a statistically significant and a clinically useful reduction of en-uresis in psychiatrically disturbed children. Its effectiveness in the non-psychiatrically disturbed child warrants further investigation. Summary A double-blind study of the use of imipramine in the treatment of nocturnal enuresis is reported. The subjects were twelve children aged six to 12 years in a children's psychiatric hospital. The drug (25 mg) or placebo was administered at 8.00 p.m. for two or four weeks at a time, the trial extending from 16 weeks to 32 weeks. For the group as a whole, the number of enuretic nights declined from 46.75% on placebo to 31.75% on drug, a reduction of 32.09%. The average enuresis per child declined from 47.25% to 30.75%, a re.duction of 34.92%. Three children showed a significant response to placebo, one of these became virtually dry. Seven of the subjects showed a signficant response to the drug, with reduction of enuretic nights of 25% or more in all, of 50% or more in three and of 70% or more in two. Relapse ,occurred on discontinuing the drug.
In addition to the fall in enuresis each time drug was given, an over-all decrease in enuresis occurred throughout the trial, not due to spontaneous improvement. It is suggested that this results from the full effects of the drug being somewhat delayed and taking some time to wear off.
Observations on the time at which enuresis occurred showed that most commonly only incidents after 1 a.m. were reduced, suggesting that for this group earlier administration of the drug may be desirable. In only one subject was enuresis before 1 a.m, accompanied by an increase in incidents after 1 a.m. and for such cases an increased dosage may be effective. No side effects from the drug were observed.
A consideration of the mode of action of the drug is presented and it is concluded that it may act by diminishing uninhibited bladder contractions by its autonomic diencephalic action. Previous reports on the treatment of enuresis by imipramine are reviewed together with a brief review of controlled studies of other drugs which have appeared in the past decade.
It is concluded that imipramine is a useful drug in the treatment of enuresis in psychiatrically disturbed children. to Dr. B. A. Hoddinott for statistical advice and to the child-care staff for data collection. Pour l'ensemble du groupe, Ie nombre de nuits avec enuresie a baisse de 46.75 p. 100 avec Ie placebo a 31.75 p. 100 avec la drogue, soit une diminution de 32.09 p. 100. L'enuresie moyenne par enfant a baisse de 47.25 p. 100 a 30.75 P: 100, soit une diminution de 34.92 p. 100. Trois enfants ont presente une reaction significative au placebo et chez l'un deux, l'enuresie a pratiquement disparu. Sept sujets ont presente une reaction significative a la drogue, avec reduction de nuits avec enuresie, de 25 p. 100 ou plus chez tous ces sujets, ou de 50 p. 100 ou plus chez trois sujets et de 70 p. 100 ou plus chez deux d'entre eux. Les recidives se sont produites lorsqu'on a cesse l'emploi de la drogue.
Outre la diminution de l'enuresie chaque fois que la drogueerait adrninistree, on a constate une diminution genernle au cours de toute l'experience, non attribuable al'amelioration spontanee. On avance que cela resulte du fait que la drogue prend un certain temps afaire sentir tous ses effetset qu'il faut un certain temps pour que ces effets disparaissent, Les observations quant au moment ou se produit l'enuresie ont montre que ces cas ont presque tous diminue apres une heure du matin, ce qui indiquerait qu'il est opportun d'administrer la drogue plus tot au cours de la soiree chez ce groupe. Un seul sujet a presente de l'enuresie avant une heure du matin, accornpagnee d'une augmentation des incidents apres une heure du matin et, dans ces cas, une dose plus forte aurait peut-etre des effets. On n'a constate aucun effet secondaire.
L'article presente une consideration du mode d'action de la drogue et conclut en disant qu'elle peut agir en diminuant les contractions non inhibees de la vessie par son action autonomique sur Ie diencephale. Des rapports anterieurs sur Ie traitement de l'enuresie par l'imipramine sont passes en revue en meme temps que les etudes controlees des autres drogues qui ont fait leur apparition au cours de la derniere decennie.
L'article conclut en disant que l'imipramine est une drogue utile pour Ie traitement de l'enuresie chez les enfants atteints de troubles psychiatriques.
